[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"app-context":3,"blog-merck-is-up-42-in-the-last-6-months-heres-where-the-stock-could-head-in-2026-FR":222},{"languages":4,"categories":41,"products":125,"competitors":149},[5,9,13,17,21,25,29,33,37],{"name":6,"code":7,"id":8},"English","EN","TGFuZ3VhZ2U6ZW4=",{"name":10,"code":11,"id":12},"Español","ES","TGFuZ3VhZ2U6ZXM=",{"name":14,"code":15,"id":16},"Português","PT","TGFuZ3VhZ2U6cHQ=",{"name":18,"code":19,"id":20},"日本語","JA","TGFuZ3VhZ2U6amE=",{"name":22,"code":23,"id":24},"한국어","KO","TGFuZ3VhZ2U6a28=",{"name":26,"code":27,"id":28},"Deutsch","DE","TGFuZ3VhZ2U6ZGU=",{"name":30,"code":31,"id":32},"Italiano","IT","TGFuZ3VhZ2U6aXQ=",{"name":34,"code":35,"id":36},"Français","FR","TGFuZ3VhZ2U6ZnI=",{"name":38,"code":39,"id":40},"中文 (中国)","ZH","TGFuZ3VhZ2U6emg=",[42,73,104],{"icon":43,"slug":44,"title":45,"description":46,"featuredLinks":47},"mingcute:stock-line","stock-market-basics","Stock Market Basics","\u003Cp>Beginners' guides and practical tips for understanding stock market investing.\u003C\u002Fp>\n",[48,53,58,63,68],{"url":49,"title":50,"description":51,"ogImage":52},"https:\u002F\u002Fwww.tikr.com\u002Fblog\u002Fwhat-makes-stocks-go-up-and-down","What Makes Stocks Go Up and Down | TIKR.com","Understanding what makes stock prices go up and down can help investors better navigate investing. Click to learn more!","https:\u002F\u002Fwww.tikr.com\u002Fimages\u002FWhat-makes-stocks-go-up-and-down-banner\u002FWhat-makes-stocks-go-up-and-down-banner.jpg?_i=AA",{"url":54,"title":55,"description":56,"ogImage":57},"https:\u002F\u002Fwww.tikr.com\u002Fblog\u002Fdividend-yield-meaning-formula-example","Dividend Yield: Meaning, Formula, Example | Tikr.com Blog | TIKR.com","The dividend yield is a key metric for investors looking to gauge the income potential of their investments. It measures how much a company pays out in","https:\u002F\u002Fwww.tikr.com\u002Fimages\u002FDividend-yield\u002FDividend-yield.png?_i=AA",{"url":59,"title":60,"description":61,"ogImage":62},"https:\u002F\u002Fwww.tikr.com\u002Fblog\u002Fmarket-capitalization-definition-formula-and-why-it-matters","Market Capitalization: Definition, Formula, and Why It Matters | TIKR.com","Long-term investors often look at various valuation metrics when deciding whether to invest in a particular company. One helpful metric to evaluate is","https:\u002F\u002Fwww.tikr.com\u002Fimages\u002FMarket-Capitalization-Definition-Formula-and-Why-It-Matters\u002FMarket-Capitalization-Definition-Formula-and-Why-It-Matters.png?_i=AA",{"url":64,"title":65,"description":66,"ogImage":67},"https:\u002F\u002Fwww.tikr.com\u002Fblog\u002Fearnings-per-share-definition-formula-and-why-eps-matters","Earnings Per Share: Definition, Formula, and Why EPS Matters | TIKR.com","Earnings Per Share (EPS) represents the portion of a company's net earnings allocated to each share. Click to learn more!","https:\u002F\u002Fwww.tikr.com\u002Fimages\u002FEPS-Defiinition-formula-and-why-EPS-matters-1\u002FEPS-Defiinition-formula-and-why-EPS-matters-1.png?_i=AA",{"url":69,"title":70,"description":71,"ogImage":72},"https:\u002F\u002Fwww.tikr.com\u002Fblog\u002Fwhat-is-a-stock-price-target","What Is a Stock Price Target? | TIKR.com","A price target is a stock's estimated future price. It can help investors quickly find undervalued stocks. Learn more now!","https:\u002F\u002Fwww.tikr.com\u002Fimages\u002FWhat-is-a-Stock-Price-Target-2\u002FWhat-is-a-Stock-Price-Target-2.png?_i=AA",{"icon":74,"slug":75,"title":76,"description":77,"featuredLinks":78},"material-symbols:analytics-outline","fundamental-analysis","Fundamental Analysis","\u003Cp>In-depth resources and financial metrics to help you evaluate companies like a pro.\u003C\u002Fp>\n",[79,84,89,94,99],{"url":80,"title":81,"description":82,"ogImage":83},"https:\u002F\u002Fwww.tikr.com\u002Fblog\u002Fshare-repurchase-why-do-companies-buy-back-their-stock","Share Repurchase: Why Do Companies Buy Back Their Stock? | TIKR.com","Share repurchases, or share buybacks, have gained popularity in the last two decades. According to a report from Goldman Sachs, stock buybacks initiated","https:\u002F\u002Fwww.tikr.com\u002Fimages\u002FTIKR-BLOG-COVER-PHOTOS-3_544a7f4e\u002FTIKR-BLOG-COVER-PHOTOS-3_544a7f4e.png?_i=AA",{"url":85,"title":86,"description":87,"ogImage":88},"https:\u002F\u002Fwww.tikr.com\u002Fblog\u002Fwhat-is-a-good-return-on-invested-capital","What Is a Good Return on Invested Capital? | TIKR.com","Learning about Return on Invested Capital (ROIC) can help investors spot highly profitable stocks that can drive long-term returns. Learn more now!","https:\u002F\u002Fwww.tikr.com\u002Fimages\u002FWhat-is-a-good-return-on-Invested-capital\u002FWhat-is-a-good-return-on-Invested-capital.png?_i=AA",{"url":90,"title":91,"description":92,"ogImage":93},"https:\u002F\u002Fwww.tikr.com\u002Fblog\u002Fwhat-is-a-good-return-on-equity-ratio","What is a Good Return on Equity Ratio | Tikr.com Blog | TIKR.com","Return on Equity (ROE) is a financial ratio that reflects a company's profitability in relation to the equity invested by shareholders. It basically","https:\u002F\u002Fwww.tikr.com\u002Fimages\u002FWhat-is-a-good-return-on-equity-ratio-1\u002FWhat-is-a-good-return-on-equity-ratio-1.jpg?_i=AA",{"url":95,"title":96,"description":97,"ogImage":98},"https:\u002F\u002Fwww.tikr.com\u002Fblog\u002Fwhat-is-a-good-p-e-ratio","What Is a Good P\u002FE Ratio? | TIKR.com","Financial analysts and investors look at various metrics before deciding whether a stock is a buy. One of the metrics is the price-to-earnings ratio (P\u002FE","https:\u002F\u002Fwww.tikr.com\u002Fimages\u002FWhat-is-a-good-PE-ratio-1\u002FWhat-is-a-good-PE-ratio-1.jpg?_i=AA",{"url":100,"title":101,"description":102,"ogImage":103},"https:\u002F\u002Fwww.tikr.com\u002Fblog\u002Ftop-6-metrics-for-investing-in-reits","Top 6 Metrics for Investing in REITs | TIKR.com","Real estate has been one of the greatest asset classes for wealth creation in history, and investing in Real Estate Investment Trusts (REITs) can allow","https:\u002F\u002Fwww.tikr.com\u002Fimages\u002FGroup-10\u002FGroup-10.png?_i=AA",{"icon":105,"slug":106,"title":107,"description":108,"featuredLinks":109},"hugeicons:investigation","investing-lingo","Investing Lingo","\u003Cp>A comprehensive glossary of investing terms and jargon so you can speak the language of the markets confidently.\u003C\u002Fp>\n",[110,115,120],{"url":111,"title":112,"description":113,"ogImage":114},"https:\u002F\u002Fwww.tikr.com\u002Fblog\u002Fenterprise-value-definition-and-calculation","Enterprise Value: Definition and Calculation | Tikr.com Blog | TIKR.com","Enterprise value (EV) is a financial metric that offers a comprehensive snapshot of a company's total value. Unlike market capitalization which solely","https:\u002F\u002Fwww.tikr.com\u002Fimages\u002FEnterprise-Value-Definition-and-Calculation_37576e40\u002FEnterprise-Value-Definition-and-Calculation_37576e40.png?_i=AA",{"url":116,"title":117,"description":118,"ogImage":119},"https:\u002F\u002Fwww.tikr.com\u002Fblog\u002Febitda-definition-formula-how-to-use-it","EBITDA: Definition, Formula, How to Use It | TIKR.com","EBITDA stands for earnings before interest, taxes, depreciation and amortization. It's a financial metric commonly used to evaluate a company's financial","https:\u002F\u002Fwww.tikr.com\u002Fimages\u002FEBITDA-Definition-Formula-How-to-Use-It\u002FEBITDA-Definition-Formula-How-to-Use-It.png?_i=AA",{"url":121,"title":122,"description":123,"ogImage":124},"https:\u002F\u002Fwww.tikr.com\u002Fblog\u002Fwhat-is-the-free-cash-flow-formula-and-why-does-it-matter","What is the Free Cash Flow Formula and Why Does It Matter | TIKR.com","Free cash flow, or FCF, is the cash a company generates after it accounts for outflows required to maintain business operations and support capital","https:\u002F\u002Fwww.tikr.com\u002Fimages\u002FWhat-is-the-free-cash-flow-formula\u002FWhat-is-the-free-cash-flow-formula.png?_i=AA",[126,130,134,137,141,145],{"slug":127,"modified":128,"title":129},"valuation-model-builder","2025-07-03T00:18:53","Value Stocks Quickly and Accurately",{"slug":131,"modified":132,"title":133},"stock-portfolio-tracking","2024-12-02T22:21:28","Monitor Your Portfolio",{"slug":75,"modified":135,"title":136},"2025-01-21T22:10:52","Instantly Analyze Companies with In-Depth Metrics",{"slug":138,"modified":139,"title":140},"stock-screener","2024-12-02T22:13:31","Find the Best Stocks to Buy",{"slug":142,"modified":143,"title":144},"investor-stock-portfolio","2025-01-21T22:02:56","Follow Investment Moves of Top Investors",{"slug":146,"modified":147,"title":148},"analyze-stocks","2025-07-23T16:04:24","Analyze Stocks",[150,154,158,162,166,170,174,178,182,186,190,194,198,202,206,210,214,218],{"slug":151,"title":152,"modified":153},"bloomberg","Bloomberg","2025-01-16T14:23:44",{"slug":155,"title":156,"modified":157},"morningstar","Morningstar","2025-01-16T14:25:16",{"slug":159,"title":160,"modified":161},"sentieo","Sentieo","2025-01-16T17:58:27",{"slug":163,"title":164,"modified":165},"googlefinance","Google Finance","2025-01-17T19:39:37",{"slug":167,"title":168,"modified":169},"tradingview","TradingView","2025-01-16T18:17:01",{"slug":171,"title":172,"modified":173},"factset","Factset","2025-01-16T18:20:16",{"slug":175,"title":176,"modified":177},"finviz","Finviz","2025-01-16T18:23:40",{"slug":179,"title":180,"modified":181},"ycharts","YCharts","2025-01-16T18:32:19",{"slug":183,"title":184,"modified":185},"marketbeat","MarketBeat","2025-03-11T00:27:23",{"slug":187,"title":188,"modified":189},"benzinga","Benzinga","2025-03-11T00:31:00",{"slug":191,"title":192,"modified":193},"gurufocus","Gurufocus","2025-03-11T00:31:12",{"slug":195,"title":196,"modified":197},"fast-graphs","FAST Graphs","2025-03-11T00:31:19",{"slug":199,"title":200,"modified":201},"tipranks","TipRanks","2025-03-11T00:31:26",{"slug":203,"title":204,"modified":205},"seeking-alpha","Seeking Alpha","2025-03-11T00:31:45",{"slug":207,"title":208,"modified":209},"thestreet","TheStreet","2025-03-11T00:31:52",{"slug":211,"title":212,"modified":213},"investing-com","Investing.com","2025-03-11T00:32:00",{"slug":215,"title":216,"modified":217},"zacks","Zacks","2025-03-26T15:40:40",{"slug":219,"title":220,"modified":221},"alphasense","AlphaSense","2025-03-11T00:32:15",{"post":223,"seo":259,"relatedPosts":265,"suggestedPosts":345},{"id":224,"title":225,"date":226,"modified":227,"excerpt":228,"content":229,"wordCount":230,"lang":231,"uri":232,"slug":233,"cloudinaryAssetId":234,"featuredImageOriginalUrl":235,"featuredImageMetadata":236,"author":239,"editor":245,"categories":250,"relatedPosts":256,"seo":257},95587,"Merck est en hausse de 42 % au cours des 6 derniers mois. Voici ce que l'action pourrait devenir en 2026","2026-03-03T19:35:00","2026-03-03T16:41:29","\u003Cp>L'action Merck a progressé de 42 % au cours des six derniers mois, et notre analyse suggère que le titre pourrait encore offrir une hausse significative jusqu'en 2026. Voici pourquoi la durabilité de l'oncologie, l'élan du pipeline et le soutien institutionnel constant continuent de soutenir la configuration.\u003C\u002Fp>\n","\n\u003Ch3 class=\"wp-block-heading\" id=\"h-key-stats-for-mrk-stock\">\u003Cstrong>Principales statistiques pour l'action MRK\u003C\u002Fstrong>\u003C\u002Fh3>\n\n\n\n\u003Cul class=\"wp-block-list\">\n\u003Cli>\u003Cstrong>Performance des 6 derniers mois :\u003C\u002Fstrong> 42%\u003C\u002Fli>\n\n\n\n\u003Cli>\u003Cstrong>Fourchette de 52 semaines : \u003C\u002Fstrong> 73 $ à 125\u003C\u002Fli>\n\n\n\n\u003Cli>\u003Cstrong>Prix cible du modèle d'évaluation :\u003C\u002Fstrong> 178\u003C\u002Fli>\n\n\n\n\u003Cli>\u003Cstrong>Hausse implicite\u003C\u002Fstrong>: 47\u003C\u002Fli>\n\u003C\u002Ful>\n\n\n\n\u003Cp>\u003Cstrong>\u003Cem>\u003Ca href=\"https:\u002F\u002Fapp.tikr.com\u002Fregister?ref=tikrblog\" target=\"_blank\" rel=\"noreferrer noopener\">\u003C\u002Fa>\u003Cstrong>\u003Cem>\u003Ca href=\"https:\u002F\u002Fapp.tikr.com\u002Fregister?ref=tikrblog\" target=\"_blank\" rel=\"noreferrer noopener\">Évaluez vos actions préférées comme Merck &amp; Co. avec 5 ans de prévisions d'analystes en utilisant le nouveau modèle d'évaluation de TIKR (c'est gratuit) &gt;&gt;&gt;\u003C\u002Fa>\u003C\u002Fem>\u003C\u002Fstrong>\u003C\u002Fem>\u003C\u002Fstrong>\u003C\u002Fp>\n\n\n\n\u003Ch2 class=\"wp-block-heading\" id=\"h-what-happened\">\u003Cstrong>\u003Cstrong>Que s'est-il passé ?\u003C\u002Fstrong>\u003C\u002Fstrong>\u003C\u002Fh2>\n\n\n\n\u003Cp>\u003Ca href=\"https:\u002F\u002Fapp.tikr.com\u002Fstock\u002Fabout?cid=288502&amp;tid=2629738&amp;ref=srk6m3\">\u003Cstrong>L'action Merck &amp; Co, Inc.\u003C\u002Fstrong>\u003C\u002Fa> a augmenté d'environ 42 % au cours des six derniers mois, se négociant récemment à près de 120 $ par action, les investisseurs étant de plus en plus confiants dans la durabilité de sa franchise oncologique et dans la visibilité de son pipeline en phase avancée de développement. \u003Cbr>\u003Cbr>Les actions ont grimpé vers le haut de leur fourchette de 73 à 125 dollars sur 52 semaines, grâce à la dynamique des bénéfices et à l'amélioration du sentiment qui a soutenu la progression.\u003C\u002Fp>\n\n\n\n\u003Cp>Le rallye a été principalement alimenté par la croissance résistante de KEYTRUDA, l'accélération des contributions des nouveaux produits et la réaffirmation par la direction des perspectives d'expansion à long terme en dépit des vents contraires connus. \u003Cbr>\u003Cbr>Les investisseurs ont fait abstraction d'environ 2,5 milliards de dollars de vents contraires attendus en 2026 en raison de la concurrence des génériques, de la fixation des prix par l'IRA et de l'accord Koselugo restructuré, car les lancements de produits oncologiques et spécialisés continuent de compenser les pressions en matière de politique et d'exclusivité.\u003C\u002Fp>\n\n\n\n\u003Cp>Cette semaine, Merck a annoncé un chiffre d'affaires de 16,4 milliards de dollars au quatrième trimestre, en hausse de 5%, grâce aux ventes de KEYTRUDA de 8,4 milliards de dollars, à la croissance de 37% de WELIREG à 220 millions de dollars, aux revenus de WINREVAIR de 467 millions de dollars et à la contribution de 178 millions de dollars d'OHTUVAYRE, tandis que GARDASIL a chuté de 35% à 1 milliard de dollars en raison d'une demande plus faible en Chine et au Japon. \u003Cbr>\u003Cbr>La direction a prévu un bénéfice par action non GAAP de 5 à 5,15 dollars pour 2026 et le PDG Rob Davis a mis l'accent sur la dynamique du pipeline, déclarant que la société a maintenant \"une ligne de mire sur plus de 70 milliards de dollars d'opportunités commerciales potentielles d'ici le milieu des années 2030\".\u003C\u002Fp>\n\n\n\n\u003Cp>Le positionnement institutionnel a été actif et a largement soutenu l'avancée. River Wealth Advisors a augmenté sa participation de 24,1 %, Quantbot Technologies a augmenté sa position de 125 %, American Century Companies a augmenté ses avoirs de 20,9 %, et Harvest Portfolios Group a ajouté 8,4 %, tandis qu'Artisan Partners a augmenté sa position de 2,6 %. \u003Cbr>\u003Cbr>Certaines sociétés ont réduit leur exposition, notamment Bedell Frazier Investment Counselling, qui a réduit sa participation de 87,3 %, Banco Santander, qui a réduit sa position de 58,3 %, et Erste Asset Management, qui a réduit la sienne de 31,9 %, mais les investisseurs institutionnels détiennent toujours environ 76,07 % de la société, ce qui renforce l'importance de la propriété à long terme derrière la reprise de six mois.\u003C\u002Fp>\n\n\n\n\u003Cfigure class=\"wp-block-image size-full\">\u003Cimg width=\"2293\" height=\"2560\" data-public-id=\"images\u002FMRK_valuation_model-4_9560486df3\u002FMRK_valuation_model-4_9560486df3.webp\" decoding=\"async\" src=\"https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_2293,h_2560,c_scale\u002Ff_webp,q_auto\u002Fv1772555213\u002Fimages\u002FMRK_valuation_model-4_9560486df3\u002FMRK_valuation_model-4_9560486df3.webp?_i=AA\" alt=\"Merck &amp; Co. stock\" class=\"wp-post-95587 wp-image-95604\" data-format=\"webp\" data-transformations=\"f_webp,q_auto\" data-version=\"1772555213\" data-seo=\"1\" \u002F>\u003Cfigcaption class=\"wp-element-caption\">Modèle d'évaluation guidée de MRK\u003C\u002Ffigcaption>\u003C\u002Ffigure>\n\n\n\n\u003Cp>\u003Cstrong>\u003Cem>\u003Ca href=\"https:\u002F\u002Fapp.tikr.com\u002Fregister?ref=tikrblog\">Voir les prévisions de croissance et les objectifs de prix des analystes pour Merck &amp; Co. (C'est gratuit) &gt;&gt;&gt;\u003C\u002Fa>\u003C\u002Fem>\u003C\u002Fstrong>\u003C\u002Fp>\n\n\n\n\u003Ch2 class=\"wp-block-heading\" id=\"h-is-mrk-undervalued\">MRK est-il sous-évalué ?\u003C\u002Fh2>\n\n\n\n\u003Cp>Dans les hypothèses de valorisation, l'action est modélisée à l'aide de :\u003C\u002Fp>\n\n\n\n\u003Cul class=\"wp-block-list\">\n\u003Cli>\u003Cstrong>Croissance du chiffre d'affaires (CAGR) :\u003C\u002Fstrong> 5%\u003C\u002Fli>\n\n\n\n\u003Cli>\u003Cstrong>Marges d'exploitation :\u003C\u002Fstrong> 38%\u003C\u002Fli>\n\n\n\n\u003Cli>\u003Cstrong>Multiple P\u002FE de sortie : \u003C\u002Fstrong>16x\u003C\u002Fli>\n\u003C\u002Ful>\n\n\n\n\u003Cp>Les perspectives de Merck jusqu'en 2026 restent ancrées par l'expansion mondiale continue de KEYTRUDA, l'adoption régulière de WINREVAIR dans l'hypertension artérielle pulmonaire et la commercialisation de nouveaux lancements dans les domaines cardiométabolique et respiratoire. \u003Cbr>\u003Cbr>L'oncologie reste le principal moteur de profit, tandis que la solidité de la marge, proche des 30 %, reflète un mélange favorable, des avantages d'échelle et un contrôle rigoureux des dépenses.\u003C\u002Fp>\n\n\n\n\u003Cfigure class=\"wp-block-image size-full\">\u003Cimg width=\"2560\" height=\"1706\" data-public-id=\"images\u002FTIKR.com_MRK-Merck-Co.-Inc.-Revenue-and-Revenue-Change-YoY-1\u002FTIKR.com_MRK-Merck-Co.-Inc.-Revenue-and-Revenue-Change-YoY-1.webp\" decoding=\"async\" src=\"https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_2560,h_1706,c_scale\u002Ff_webp,q_auto\u002Fv1772555198\u002Fimages\u002FTIKR.com_MRK-Merck-Co.-Inc.-Revenue-and-Revenue-Change-YoY-1\u002FTIKR.com_MRK-Merck-Co.-Inc.-Revenue-and-Revenue-Change-YoY-1.webp?_i=AA\" alt=\"Merck &amp; Co. stock\" class=\"wp-post-95587 wp-image-95605\" data-format=\"webp\" data-transformations=\"f_webp,q_auto\" data-version=\"1772555198\" data-seo=\"1\" \u002F>\u003Cfigcaption class=\"wp-element-caption\">Estimations des revenus de MRK et de la croissance des analystes sur cinq ans\u003C\u002Ffigcaption>\u003C\u002Ffigure>\n\n\n\n\u003Cp>Au cours de l'année prochaine, les performances dépendront de trois facteurs mesurables : la croissance soutenue du volume de KEYTRUDA dans les indications de stade précoce, la stabilisation de la demande de GARDASIL en Chine et l'exécution de la lecture du pipeline de stade avancé dans les programmes d'oncologie, de VIH et de cardiométabolisme. \u003Cbr>\u003Cbr>Plusieurs étapes de la phase III et des décisions réglementaires prévues jusqu'en 2026 pourraient influencer de manière significative la manière dont les investisseurs évaluent la durabilité des bénéfices post-KEYTRUDA.\u003C\u002Fp>\n\n\n\n\u003Cp>La génération de flux de trésorerie disponibles continue de soutenir la stabilité des dividendes et la flexibilité stratégique pour le développement d'activités supplémentaires. \u003Cbr>\u003Cbr>À environ 120 dollars par action et se négociant à près de 16 fois les bénéfices selon ces hypothèses, l'action semble légèrement sous-évaluée par rapport à son profil de marge et à l'optionnalité de son pipeline. \u003Cbr>\u003Cbr>Si la croissance de l'oncologie et l'exécution clinique restent intactes, Merck est positionnée pour une croissance régulière, basée sur la qualité des bénéfices et l'expansion des opportunités commerciales plutôt que sur une expansion à court terme des multiples.\u003C\u002Fp>\n\n\n\n\u003Cp>\u003Cstrong>\u003Cem>\u003Cstrong>\u003Cem>\u003Cstrong>\u003Cem>\u003Ca href=\"https:\u002F\u002Fapp.tikr.com\u002Fregister?ref=tikrblog\" target=\"_blank\" rel=\"noreferrer noopener\">Estimez instantanément la juste valeur d'une société (gratuit avec TIKR) &gt;&gt;&gt;\u003C\u002Fa>\u003C\u002Fem>\u003C\u002Fstrong>\u003C\u002Fem>\u003C\u002Fstrong>\u003C\u002Fem>\u003C\u002Fstrong>\u003C\u002Fp>\n\n\n\n\u003Ch2 class=\"wp-block-heading\" id=\"h-how-much-upside-does-mrk-stock-have-from-here\">\u003Cstrong>\u003Cstrong>\u003Cstrong>Quelle est l'ampleur de la hausse de l'action MRK à partir de maintenant ?\u003C\u002Fstrong>\u003C\u002Fstrong>\u003C\u002Fstrong>\u003C\u002Fh2>\n\n\n\n\u003Cp>Les investisseurs peuvent estimer le prix potentiel de l'action de Merck &amp; Co., ou ce que toute action pourrait valoir, en moins d'une minute à l'aide de l'\u003Cstrong>outil Nouveau modèle d'évaluation de TIKR\u003C\u002Fstrong>.\u003C\u002Fp>\n\n\n\n\u003Cp>Tout ce qu'il faut, ce sont trois données simples :\u003C\u002Fp>\n\n\n\n\u003Col class=\"wp-block-list\">\n\u003Cli>Croissance du chiffre d'affaires\u003C\u002Fli>\n\n\n\n\u003Cli>Marges d'exploitation\u003C\u002Fli>\n\n\n\n\u003Cli>Multiplicateur de prix de sortie\u003C\u002Fli>\n\u003C\u002Fol>\n\n\n\n\u003Cp>TIKR calcule ensuite le prix potentiel de l'action et le rendement total dans le cadre de \u003Cstrong>scénarios\u003C\u002Fstrong> \u003Cstrong>haussiers, baissiers et de base,\u003C\u002Fstrong> ce qui vous permet de voir rapidement si une action semble \u003Cstrong>sous-évaluée ou surévaluée\u003C\u002Fstrong>.\u003C\u002Fp>\n\n\n\n\u003Cp>Si vous n'êtes pas sûr de ce qu'il faut saisir, TIKR remplit automatiquement chaque entrée en utilisant les estimations consensuelles des analystes, ce qui vous donne un point de départ rapide et fiable.\u003C\u002Fp>\n\n\n\n\u003Cp>\u003Cstrong>\u003Cem>\u003Ca href=\"https:\u002F\u002Fapp.tikr.com\u002Fregister?ref=tikrblog\" target=\"_blank\" rel=\"noreferrer noopener\">Découvrez la valeur réelle de Merck &amp; Co., ou de toute autre action, en moins de 60 secondes (gratuit avec TIKR) &gt;&gt;&gt;\u003C\u002Fa>\u003C\u002Fem>\u003C\u002Fstrong>\u003C\u002Fp>\n",705,"fr","\u002Fblog\u002Fmerck-is-up-42-in-the-last-6-months-heres-where-the-stock-could-head-in-2026","merck-is-up-42-in-the-last-6-months-heres-where-the-stock-could-head-in-2026","images\u002F@TrueCreatives-via-Canva-123\u002F@TrueCreatives-via-Canva-123","https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_600,h_400,c_scale\u002Ff_webp,q_auto\u002Fv1772556024\u002Fimages\u002F@TrueCreatives-via-Canva-123\u002F@TrueCreatives-via-Canva-123.png?_i=AA",{"altText":237,"imageCredit":238},"Merck Is Up 42% in the Last 6 Months. Here’s Where the Stock Could Head in 2026","@TrueCreatives via Canva",{"name":240,"slug":241,"role":242,"roleTitle":243,"biography":243,"avatar":243,"socialMediaLinks":244},"Nikko Henson","nikkotikr","author","",[],{"name":246,"slug":247,"role":248,"roleTitle":243,"biography":243,"avatar":243,"socialMediaLinks":249},"Thomas Richmond","thomastikr","editor",[],[251],{"name":252,"slug":253,"uri":254,"description":243,"postsCount":255},"Examens des Actions","reviews","\u002Fblog\u002Fcategory\u002Freviews",0,[],{"title":237,"metaDesc":258,"opengraphDescription":258,"twitterTitle":237,"twitterDescription":258},"Merck stock is up 42% over the past six months, and our analysis suggests the stock could still deliver meaningful upside into 2026. Here’s why oncology durability, pipeline momentum, and steady institutional support continue to underpin the setup.",{"title":237,"description":258,"twitterTitle":237,"twitterDescription":258,"author":240,"articlePublisher":260,"articlePublishedTime":226,"articleModifiedTime":227,"twitterLabel1":261,"twitterData1":262,"ogTitle":237,"ogDescription":258,"ogUrl":232,"ogImage":235,"ogImageWidth":263,"ogImageHeight":264,"ogImageSecureUrl":235,"ogImageAlt":237,"twitterImage":235},"TIKR.com","Temps de lecture estimé","6 minutes",1200,630,[266,281,298,314,329],{"id":255,"title":267,"date":268,"excerpt":269,"wordCount":270,"uri":271,"slug":272,"cloudinaryAssetId":273,"featuredImageOriginalUrl":274,"featuredImageMetadata":275,"author":276,"categories":278,"relatedPosts":280},"LyondellBasell est en hausse de 28 % depuis le début de l'année. Voici où les actions pourraient aller en 2026","2026-03-03 19:05:00","L'action LyondellBasell est en hausse de 28 % depuis le début de l'année en 2026, car le resserrement des stocks de polyéthylène et la forte génération de liquidités soutiennent l'idée d'un rebond. Voici pourquoi le redressement des marges et la discipline en matière d'approvisionnement pourraient encore entraîner une hausse significative par rapport aux niveaux actuels.",790,"\u002Fblog\u002Flyondellbasell-is-up-28-year-to-date-heres-where-shares-could-go-in-2026","lyondellbasell-is-up-28-year-to-date-heres-where-shares-could-go-in-2026","images\u002F@Stas_V-from-Getty-Images-via-Canva-213\u002F@Stas_V-from-Getty-Images-via-Canva-213","https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_600,h_400,c_scale\u002Ff_webp,q_auto\u002Fv1772552857\u002Fimages\u002F@Stas_V-from-Getty-Images-via-Canva-213\u002F@Stas_V-from-Getty-Images-via-Canva-213.png?_i=AA",{"altText":267},{"name":240,"slug":241,"role":242,"roleTitle":243,"biography":243,"avatar":243,"socialMediaLinks":277},[],[279],{"name":252,"slug":253,"uri":254,"description":243,"postsCount":255},[],{"id":255,"title":282,"date":283,"excerpt":284,"wordCount":285,"uri":286,"slug":287,"cloudinaryAssetId":288,"featuredImageOriginalUrl":289,"featuredImageMetadata":290,"author":291,"categories":295,"relatedPosts":297},"L'action GE Healthcare à 80$ : Pourquoi les analystes voient une hausse de 35 % ?","2026-03-03 19:00:00","GEHC vient d'obtenir l'autorisation de la FDA pour trois systèmes d'IRM et de conclure une nouvelle facilité de crédit de 500 millions de dollars, mais le véritable catalyseur, à savoir l'autorisation de Photonova et l'augmentation de la dose de Flyrcado, n'a pas encore eu lieu.",761,"\u002Fblog\u002Fge-healthcare-stock-at-80-why-analysts-see-35-upside","ge-healthcare-stock-at-80-why-analysts-see-35-upside","images\u002FFEATURED-IMAGE-MAKER-392\u002FFEATURED-IMAGE-MAKER-392","https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_600,h_360,c_scale\u002Ff_webp,q_auto\u002Fv1772545982\u002Fimages\u002FFEATURED-IMAGE-MAKER-392\u002FFEATURED-IMAGE-MAKER-392.png?_i=AA",{"altText":282},{"name":292,"slug":293,"role":242,"roleTitle":243,"biography":243,"avatar":243,"socialMediaLinks":294},"Gian Estrada","giantikr",[],[296],{"name":252,"slug":253,"uri":254,"description":243,"postsCount":255},[],{"id":255,"title":299,"date":283,"excerpt":300,"wordCount":301,"uri":302,"slug":303,"cloudinaryAssetId":304,"featuredImageOriginalUrl":305,"featuredImageMetadata":306,"author":307,"categories":311,"relatedPosts":313},"L'action RCUS bondit de 17,5 % malgré une perte nette de 353 millions de dollars : ce que la juste valeur de 34 $ indique","Voici pourquoi l'action d'Arcus Biosciences a bondi de 17,5 % pour atteindre 24 dollars, les données cliniques et une trésorerie de 981 millions de dollars ayant compensé les pertes croissantes.",660,"\u002Fblog\u002Frcus-stock-jumps-17-5-despite-353m-net-loss-what-34-fair-value-signals","rcus-stock-jumps-17-5-despite-353m-net-loss-what-34-fair-value-signals","images\u002FRCUS-stock\u002FRCUS-stock","https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_600,h_400,c_scale\u002Ff_webp,q_auto\u002Fv1772563814\u002Fimages\u002FRCUS-stock\u002FRCUS-stock.png?_i=AA",{"altText":299},{"name":308,"slug":309,"role":242,"roleTitle":243,"biography":243,"avatar":243,"socialMediaLinks":310},"Rexielyn Diaz","rexietikr",[],[312],{"name":252,"slug":253,"uri":254,"description":243,"postsCount":255},[],{"id":255,"title":315,"date":316,"excerpt":317,"wordCount":318,"uri":319,"slug":320,"cloudinaryAssetId":321,"featuredImageOriginalUrl":322,"featuredImageMetadata":323,"author":324,"categories":326,"relatedPosts":328},"L'action AXT bondit de 22% à 46 dollars : pourquoi les analystes voient toujours une juste valeur de 27 dollars","2026-03-03 18:50:00","Voici pourquoi l'action AXT a bondi de 22,2 % pour atteindre 46 $, les investisseurs regardant au-delà des faibles marges et vers une croissance prévue de 42 % du chiffre d'affaires.",674,"\u002Fblog\u002Faxt-stock-surges-22-to-46-why-analysts-still-see-27-fair-value","axt-stock-surges-22-to-46-why-analysts-still-see-27-fair-value","images\u002FAXTI-stock\u002FAXTI-stock","https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_600,h_400,c_scale\u002Ff_webp,q_auto\u002Fv1772562833\u002Fimages\u002FAXTI-stock\u002FAXTI-stock.png?_i=AA",{"altText":315},{"name":308,"slug":309,"role":242,"roleTitle":243,"biography":243,"avatar":243,"socialMediaLinks":325},[],[327],{"name":252,"slug":253,"uri":254,"description":243,"postsCount":255},[],{"id":255,"title":330,"date":331,"excerpt":332,"wordCount":333,"uri":334,"slug":335,"cloudinaryAssetId":336,"featuredImageOriginalUrl":337,"featuredImageMetadata":338,"author":340,"categories":342,"relatedPosts":344},"Johnson & Johnson a progressé de 38% au cours des 6 derniers mois. Voici ce que l'action pourrait devenir en 2026","2026-03-03 18:35:00","Johnson & Johnson a bondi d'environ 38 % au cours des six derniers mois, et notre analyse suggère que le titre pourrait encore offrir une hausse régulière jusqu'en 2026. Voici pourquoi l'accélération de la croissance de l'oncologie et l'expansion des marges continuent de soutenir la configuration.",691,"\u002Fblog\u002Fjohnson-johnson-has-rallied-38-in-the-last-6-months-heres-where-the-stock-could-head-in-2026","johnson-johnson-has-rallied-38-in-the-last-6-months-heres-where-the-stock-could-head-in-2026","images\u002F@Sergiu-Rusus-Images-via-Canva\u002F@Sergiu-Rusus-Images-via-Canva","https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_600,h_400,c_scale\u002Ff_webp,q_auto\u002Fv1772549656\u002Fimages\u002F@Sergiu-Rusus-Images-via-Canva\u002F@Sergiu-Rusus-Images-via-Canva.png?_i=AA",{"altText":339},"Johnson &amp; Johnson a progressé de 38% au cours des 6 derniers mois. Voici ce que l'action pourrait devenir en 2026",{"name":240,"slug":241,"role":242,"roleTitle":243,"biography":243,"avatar":243,"socialMediaLinks":341},[],[343],{"name":252,"slug":253,"uri":254,"description":243,"postsCount":255},[],[346,366,381,396,413,428,446,460,475,489],{"id":255,"title":347,"date":348,"excerpt":349,"wordCount":350,"uri":351,"slug":352,"cloudinaryAssetId":353,"featuredImageOriginalUrl":354,"featuredImageMetadata":355,"author":356,"categories":360,"relatedPosts":365},"Barclays ramène la note de l'action Blue Owl à \"Equal Weight\" alors que la chute du cours de l'action se poursuit","2026-03-03 11:59:00","Barclays abaisse la note de Blue Owl Capital en raison d'un fort ralentissement des entrées de capitaux dans les BDC non cotées et d'une forte augmentation des rachats. L'action a baissé de 50 % au cours de l'année écoulée en raison des craintes liées au crédit.",775,"\u002Fblog\u002Fbarclays-cuts-blue-owl-nyse-owl-stock-rating-equal-weight-price-plunge","barclays-cuts-blue-owl-nyse-owl-stock-rating-equal-weight-price-plunge","images\u002FOWL-stock-1\u002FOWL-stock-1","https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_600,h_400,c_scale\u002Ff_webp,q_auto\u002Fv1772533744\u002Fimages\u002FOWL-stock-1\u002FOWL-stock-1.png?_i=AA",{"altText":347},{"name":357,"slug":358,"role":242,"roleTitle":243,"biography":243,"avatar":243,"socialMediaLinks":359},"Aditya Raghunath","adityatikr",[],[361],{"name":362,"slug":363,"uri":364,"description":243,"postsCount":255},"Investissement Général","general-investing","\u002Fblog\u002Fcategory\u002Fgeneral-investing",[],{"id":255,"title":367,"date":368,"excerpt":369,"wordCount":370,"uri":371,"slug":372,"cloudinaryAssetId":373,"featuredImageOriginalUrl":374,"featuredImageMetadata":375,"author":376,"categories":378,"relatedPosts":380},"L'action Novo Nordisk atteint son plus bas niveau en 52 semaines, Goldman Sachs la rétrograde à \"neutre\".","2026-03-03 10:55:00","L'action Block a augmenté de plus de 20 % après que la société fintech a annoncé qu'elle allait licencier plus de 4 000 employés, soit environ la moitié de ses effectifs.",655,"\u002Fblog\u002Fnovo-nordisk-nyse-nvo-stock-hits-52-week-low-as-goldman-sachs-downgrades-it-to-neutral","novo-nordisk-nyse-nvo-stock-hits-52-week-low-as-goldman-sachs-downgrades-it-to-neutral","images\u002FNVO-stock_954941bea1\u002FNVO-stock_954941bea1","https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_600,h_400,c_scale\u002Ff_webp,q_auto\u002Fv1772532602\u002Fimages\u002FNVO-stock_954941bea1\u002FNVO-stock_954941bea1.png?_i=AA",{"altText":367},{"name":357,"slug":358,"role":242,"roleTitle":243,"biography":243,"avatar":243,"socialMediaLinks":377},[],[379],{"name":362,"slug":363,"uri":364,"description":243,"postsCount":255},[],{"id":255,"title":382,"date":383,"excerpt":384,"wordCount":385,"uri":386,"slug":387,"cloudinaryAssetId":388,"featuredImageOriginalUrl":389,"featuredImageMetadata":390,"author":391,"categories":393,"relatedPosts":395},"Le financement massif d'OpenAI déclenche la chute des actions d'Amazon","2026-03-02 10:30:00","L'action d'Amazon a chuté après la levée de fonds de 110 milliards de dollars d'OpenAI, malgré l'engagement d'Amazon à hauteur de 50 milliards de dollars et la conclusion d'un accord de partenariat majeur avec AWS.",831,"\u002Fblog\u002Fopenai-massive-funding-round-triggers-selloff-in-amazon-nasdaq-amzn-stock","openai-massive-funding-round-triggers-selloff-in-amazon-nasdaq-amzn-stock","images\u002FAMZN-stock-1\u002FAMZN-stock-1","https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_600,h_400,c_scale\u002Ff_webp,q_auto\u002Fv1772278707\u002Fimages\u002FAMZN-stock-1\u002FAMZN-stock-1.png?_i=AA",{"altText":382},{"name":357,"slug":358,"role":242,"roleTitle":243,"biography":243,"avatar":243,"socialMediaLinks":392},[],[394],{"name":362,"slug":363,"uri":364,"description":243,"postsCount":255},[],{"id":255,"title":397,"date":398,"excerpt":399,"wordCount":400,"uri":401,"slug":402,"cloudinaryAssetId":403,"featuredImageOriginalUrl":404,"featuredImageMetadata":405,"author":406,"categories":410,"relatedPosts":412},"L'action Chime bondit de 14 % sur la voie de la rentabilité selon les GAAP : voici où l'action pourrait se diriger en 2026","2026-03-01 15:00:00","Les actions de Chime Financial (CHYM) sont en train d'enregistrer une forte hausse après la publication de leurs résultats, suite à la publication d'un rapport sur le quatrième trimestre qui a fait date.",743,"\u002Fblog\u002Fchime-stock-surges-14-on-path-to-gaap-profitability-heres-where-the-stock-could-be-headed-in-2026","chime-stock-surges-14-on-path-to-gaap-profitability-heres-where-the-stock-could-be-headed-in-2026","images\u002F21-2\u002F21-2","https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_600,h_400,c_scale\u002Ff_webp,q_auto\u002Fv1772322176\u002Fimages\u002F21-2\u002F21-2.png?_i=AA",{"altText":397},{"name":407,"slug":408,"role":242,"roleTitle":243,"biography":243,"avatar":243,"socialMediaLinks":409},"Wiltone Asuncion","wiltonetikr",[],[411],{"name":362,"slug":363,"uri":364,"description":243,"postsCount":255},[],{"id":255,"title":414,"date":415,"excerpt":416,"wordCount":417,"uri":418,"slug":419,"cloudinaryAssetId":420,"featuredImageOriginalUrl":421,"featuredImageMetadata":422,"author":423,"categories":425,"relatedPosts":427},"L'action de Crescent Energy bondit de 7 % grâce à des synergies doublées dans le Permien : Voici où l'action pourrait aller en 2026","2026-03-01 14:50:00","Crescent Energy Company (CRGY) aborde l'année 2026 en tant qu'opérateur multi-bassins à grande échelle, après avoir réalisé des transactions d'une valeur de près de 5 milliards de dollars. ",816,"\u002Fblog\u002Fcrescent-energy-stock-surges-7-on-doubled-permian-synergies-heres-where-the-stock-could-go-in-2026","crescent-energy-stock-surges-7-on-doubled-permian-synergies-heres-where-the-stock-could-go-in-2026","images\u002F20-2\u002F20-2","https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_600,h_400,c_scale\u002Ff_webp,q_auto\u002Fv1772322164\u002Fimages\u002F20-2\u002F20-2.png?_i=AA",{"altText":414},{"name":407,"slug":408,"role":242,"roleTitle":243,"biography":243,"avatar":243,"socialMediaLinks":424},[],[426],{"name":362,"slug":363,"uri":364,"description":243,"postsCount":255},[],{"id":255,"title":429,"date":430,"excerpt":431,"wordCount":432,"uri":433,"slug":434,"cloudinaryAssetId":435,"featuredImageOriginalUrl":436,"featuredImageMetadata":437,"author":438,"categories":440,"relatedPosts":445},"En baisse de 25 % par rapport à son plus haut niveau historique, l'action Capital One peut-elle offrir de meilleurs rendements en 2026 ?","2026-03-03 11:25:00","L'action Capital One pourrait générer des rendements de 30 % d'ici 2028, l'intégration de Discover et l'acquisition de Brex débloquant la croissance du réseau de paiements et l'expansion des services bancaires aux entreprises.",1309,"\u002Fblog\u002Fdown-25-from-all-time-high-can-capital-one-nyse-stock-deliver-better-returns-in-2026","down-25-from-all-time-high-can-capital-one-nyse-stock-deliver-better-returns-in-2026","images\u002FCOF-stock\u002FCOF-stock","https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_600,h_400,c_scale\u002Ff_webp,q_auto\u002Fv1772516734\u002Fimages\u002FCOF-stock\u002FCOF-stock.png?_i=AA",{"altText":429},{"name":357,"slug":358,"role":242,"roleTitle":243,"biography":243,"avatar":243,"socialMediaLinks":439},[],[441],{"name":442,"slug":443,"uri":444,"description":243,"postsCount":255},"Évaluation","valuation","\u002Fblog\u002Fcategory\u002Fvaluation",[],{"id":255,"title":447,"date":368,"excerpt":448,"wordCount":449,"uri":450,"slug":451,"cloudinaryAssetId":452,"featuredImageOriginalUrl":453,"featuredImageMetadata":454,"author":455,"categories":457,"relatedPosts":459},"En hausse de 20 % au cours des 12 derniers mois, l'action Synchrony Financial peut-elle évoluer à la hausse en 2026 ?","En hausse de 20% sur 12 mois, Synchrony Financial est prometteur avec la croissance du partenariat avec Walmart. Notre modèle prévoit une hausse de 27 % à 87 $ d'ici décembre 2028. Analyse à l'intérieur.",1261,"\u002Fblog\u002Fup-20-in-last-12-months-can-synchrony-financial-syf-stock-deliver-further-in-2026","up-20-in-last-12-months-can-synchrony-financial-syf-stock-deliver-further-in-2026","images\u002FSYF-stock\u002FSYF-stock","https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_600,h_400,c_scale\u002Ff_webp,q_auto\u002Fv1772512295\u002Fimages\u002FSYF-stock\u002FSYF-stock.png?_i=AA",{"altText":447},{"name":357,"slug":358,"role":242,"roleTitle":243,"biography":243,"avatar":243,"socialMediaLinks":456},[],[458],{"name":442,"slug":443,"uri":444,"description":243,"postsCount":255},[],{"id":255,"title":461,"date":462,"excerpt":463,"wordCount":464,"uri":465,"slug":466,"cloudinaryAssetId":467,"featuredImageOriginalUrl":468,"featuredImageMetadata":469,"author":470,"categories":472,"relatedPosts":474},"En hausse de 42 % en 3 ans, l'action de Raymond James Financial peut-elle continuer à progresser ?","2026-03-03 09:55:00","L'action Raymond James a baissé de 10 % en 12 mois. Un fort recrutement, 31 milliards de dollars de nouveaux actifs nets signalent une reprise. Notre modèle prévoit une hausse de 21 % pour atteindre 185 $ d'ici septembre 2028.",1234,"\u002Fblog\u002Fup-42-in-3-years-can-raymond-james-financial-nyse-rjf-stock-deliver-further","up-42-in-3-years-can-raymond-james-financial-nyse-rjf-stock-deliver-further","images\u002FRJF-stock_9542509878\u002FRJF-stock_9542509878","https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_600,h_400,c_scale\u002Ff_webp,q_auto\u002Fv1772467602\u002Fimages\u002FRJF-stock_9542509878\u002FRJF-stock_9542509878.png?_i=AA",{"altText":461},{"name":357,"slug":358,"role":242,"roleTitle":243,"biography":243,"avatar":243,"socialMediaLinks":471},[],[473],{"name":442,"slug":443,"uri":444,"description":243,"postsCount":255},[],{"id":255,"title":476,"date":462,"excerpt":477,"wordCount":478,"uri":479,"slug":480,"cloudinaryAssetId":481,"featuredImageOriginalUrl":482,"featuredImageMetadata":483,"author":484,"categories":486,"relatedPosts":488},"En hausse de 19% au cours des 12 derniers mois, les valeurs financières régionales peuvent-elles encore progresser en 2026 ?","Des bénéfices solides au quatrième trimestre et un taux de rendement des capitaux propres de 18 % placent Regions Financial en position de croissance. Notre modèle prévoit une hausse de 26 % pour atteindre 35 $ d'ici 2028. L'action RF peut-elle tenir ses promesses en 2026 ?",1264,"\u002Fblog\u002Fup-19-in-last-12-months-can-regional-financial-nyse-stock-deliver-better-returns-in-2026","up-19-in-last-12-months-can-regional-financial-nyse-stock-deliver-better-returns-in-2026","images\u002FRF-stock_953648bd63\u002FRF-stock_953648bd63","https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_600,h_400,c_scale\u002Ff_webp,q_auto\u002Fv1772446487\u002Fimages\u002FRF-stock_953648bd63\u002FRF-stock_953648bd63.png?_i=AA",{"altText":476},{"name":357,"slug":358,"role":242,"roleTitle":243,"biography":243,"avatar":243,"socialMediaLinks":485},[],[487],{"name":442,"slug":443,"uri":444,"description":243,"postsCount":255},[],{"id":255,"title":490,"date":491,"excerpt":492,"wordCount":493,"uri":494,"slug":495,"cloudinaryAssetId":496,"featuredImageOriginalUrl":497,"featuredImageMetadata":498,"author":499,"categories":501,"relatedPosts":503},"En baisse de 65 % par rapport à son plus haut niveau historique, l'action Brown-Forman peut-elle offrir de meilleurs résultats en 2026 ?","2026-03-03 09:45:00","L'action Brown-Forman pourrait atteindre 36 dollars d'ici 2028 grâce au succès du Blackberry de Jack Daniel et à la croissance des marchés émergents, malgré des vents contraires à court terme dans le secteur de la consommation.",1334,"\u002Fblog\u002Fdown-65-from-all-time-high-can-brown-forman-nyse-stock-deliver-better-results-in-2026","down-65-from-all-time-high-can-brown-forman-nyse-stock-deliver-better-results-in-2026","images\u002FBFB-stock\u002FBFB-stock","https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_600,h_400,c_scale\u002Ff_webp,q_auto\u002Fv1772433508\u002Fimages\u002FBFB-stock\u002FBFB-stock.png?_i=AA",{"altText":490},{"name":357,"slug":358,"role":242,"roleTitle":243,"biography":243,"avatar":243,"socialMediaLinks":500},[],[502],{"name":442,"slug":443,"uri":444,"description":243,"postsCount":255},[]]